From overdiagnosis to overtreatment of small renal mas- can the chain be broken?

Area of Science:

• Nephrology
• Oncology
• Urology

Background:

• Small renal tumors (nephromas) under 4 cm are increasingly detected due to advanced imaging.
• These tumors display significant variability in aggressiveness, posing diagnostic challenges.
• Overtreatment of small renal tumors, particularly in elderly patients with comorbidities, can lead to more harm than benefit.

Purpose of the Study:

• To address the challenge of active surveillance for small renal tumors.
• To identify methods for distinguishing indolent tumors from those requiring intervention.
• To optimize treatment strategies for small renal tumors, balancing benefits and risks.

Main Methods:

• Review of current diagnostic and management strategies for small renal tumors.
• Analysis of the safety and efficacy of active surveillance protocols.
• Evaluation of biopsy techniques for tumor characterization.

Main Results:

• Surgical intervention for small renal tumors often results in net harm, especially in elderly or comorbid populations.
• Current biopsy methods for renal tumors are considered safe.
• The primary challenge in active surveillance is the timely detection of tumor progression.

Conclusions:

• Active surveillance is a viable strategy for select small renal tumors.
• Identifying progression markers is crucial for successful active surveillance.
• Minimizing overtreatment is essential for improving patient outcomes in small renal tumor management.